Tag:
Illumina
Latest Headlines
Latest Headlines
Patent suit loss tanks Illumina's strong sales quarter
Illumina put up another stellar revenue quarter, pulling in $331 million, a 21% jump over last year. But last month's lost patent suit to Syntrix Biosystems tacked on a $106.9 million charge, leaving the sequencing heavyweight with a $23 million net loss on the quarter.
Illumina reaches into China with diagnostics partnership
Illumina is teaming up with Chinese diagnostic lab Kindstar Global, licensing its TruSight sequencing technology for use in the fast-growing local market.
Illumina fends off Life Tech in patent spat
Illumina won a favorable court ruling this week as a district judge said its gene sequencing devices didn't violate three patents asserted by Life Technologies.
Reuters: Roche jumps into bidding for lab equipment maker Life Tech
After failing in its bid for Illumina last year, the Swiss drugmaker has reportedly joined the bidding for Life Technologies, another diagnostics-focused company that sells lab equipment and supplies, including DNA-sequencing machines.
Report: Roche dives into Life Tech bidding war
Roche may be jumping into the diagnostics M&A pool once again, a year after Illumina spurned its $6.8 billion offer. Reuters reports that the Swiss pharmaceutical company is joining a bidding war for Life Technologies.
Genomics player Illumina whacked with hefty patent case loss
A Washington court ruled against Illumina in a patent lawsuit Thursday, finding that the sequencing giant infringed on Syntrix Biosystems' intellectual property and ordering the company to pay out $96 million in damages.
Illumina must fork over $96M in patent suit
A Washington court ruled against Illumina in a patent lawsuit Thursday, finding that the sequencing giant infringed on Syntrix Biosystems' intellectual property and ordering the company to pay out $96 million in damages.
Spiral Genetics scores $3M VC round from major backer
After advancing a set of DNA data analysis tools to market, Seattle startup Spiral Genetics has latched onto some serious venture money, nailing down a $3 million Series A round from DFJ.
Genomic analysis startup scores VA contract for major study
Personalis emerged from the crowd of new genomic analysis outfits with news of a contract from the U.S. Department of Veterans Affairs (VA).
SynapDx, Illumina ally to develop autism diagnostic tools
SynapDx is allying with gene sequencer Illumina to explore development of diagnostic tools for autism spectrum disorders and other "opportunities in neurodevelopment."
